Work

Advances in Cervical Cancer

Year: 2025

Type: article

Abstract: Cervical cancer continues to represent an immense burden worldwide. Fortunately, in all stages of the disease and therapeutic modalities there have been significant advances in the past 5 years with the promise of improving oncologic outcomes and decreasing morbidity. The introduction of immunotherapy into the care of patients with metastatic and recurrent cervical cancer, a disease with a historically poor prognosis and limited treatment options, has altered the standard of care.

Source: Hematology/Oncology Clinics of North America

DOI: 10.1016/j.hoc.2025.04.016

Authors: Olivia W. Foley, Danielle Strom, Emily M. Hinchcliff

Institutions: Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,950